Findings were presented by researchers from the UC Irvine Health School of Medicine at the 2023 American Society for Preventive Cardiology's Congress on CVD Prevention.
Abdominal obesity is a predictor of isolated systolic hypertension (ISH) among individuals with obesity, according to new research1 presented at the American Society for Preventive Cardiology's Congress CVD Prevention. The meeting took place from July 21-23 in Arlington, Texas.
Around half of all US adults have hypertension, and the condition is a key contributor to cardiovascular disease (CVD).
ISH is most common among individuals aged 70 and older, according to the Cleveland Clinic.2 It is estimated that around 15% of those aged 60 and older have ISH; however, younger individuals can also be affected by the condition, which increases the risk of death and kidney failure along with CVD.
Although previous research shows that obesity is a risk factor for essential hypertension, “limited data exist on the association between [hypertension] subtypes and obesity,” the researchers wrote.
To address this knowledge gap, the investigators carried out a retrospective analysis of data gleaned from the National Health and Nutrition Examination Survey collected between 1999 and 2016.
All patients with systolic blood pressure of at least 130 mm Hg were included in the study, along with those with diastolic blood pressure of at least 80 mm Hg who were not being treated with antihypertensive drugs.
Investigators looked at everyone’s body mass index (BMI). Those with a BMI of 18.5 to 24.99 kg/m2 were considered healthy, and those with a BMI of 25 to 29.99 kg/m2 were classified as overweight. Any individual with a BMI of 30 kg/m2 or more was considered obese.
Abdominal obesity was also defined as any waste circumference greater than 102 cm among men and over 88 cm among women.
Three hypertension subtypes were considered: isolated diastolic hypertension (IDH), ISH, and systolic-diastolic hypertension.
Analyses revealed these results:
“IDH is more common in individuals with obesity than those without,” the authors wrote, adding their results showed that within the context of obesity, abdominal obesity is a predictor of ISH.
“Systolic blood pressure control may warrant greater focus in healthy weight and overweight individuals with abdominal obesity,” they said.
Abdominal fat is associated with a host of health concerns, including metabolic disturbances, heightened risks of cardiovascular disease and type 2 diabetes, and breast cancer among women, experts at Harvard Medical School write.3 Also called visceral fat, it has been associated with higher cholesterol and insulin resistance.
“One reason excess visceral fat is so harmful could be its location near the portal vein, which carries blood from the intestinal area to the liver,” they explained. Once substances are released from the visceral fat and travel to the liver, they can impact blood lipid production, they added.
Both hereditary and hormonal factors influence where fat ends up on the body. Compared with subcutaneous fat, abdominal or visceral fat cannot be pinched.
Spending at least 30 minutes each day performing moderate-intensity physical activity and integrating strength training into exercise routines can help reduce abdominal fat.
References
1. Jones JE, Tang KS, Bang M, Fan W, Wong ND. Obesity and waist circumference as predictors of hypertension subtypes. Presented at:American Society for Preventive Cardiology's Congress on CVD Prevention; July 21-23, 2023; Arlington, TX. Poster 157.
2. Isolated systolic hypertension. Cleveland Clinic. Updated January 31, 2023. Accessed July 30, 2023. https://my.clevelandclinic.org/health/diseases/24666-isolated-systolic-hypertension
3. Abdominal fat and what to do about it. Harvard Medical School. June 25, 2019. Accessed July 30, 2023. https://www.health.harvard.edu/staying-healthy/abdominal-fat-and-what-to-do-about-it
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More